Publication: Improving the estimation of the global burden of antimicrobial resistant infections
Issued Date
2019-11-01
Resource Type
ISSN
14744457
14733099
14733099
Other identifier(s)
2-s2.0-85073606951
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Infectious Diseases. Vol.19, No.11 (2019), e392-e398
Suggested Citation
Direk Limmathurotsakul, Susanna Dunachie, Keiji Fukuda, Nicholas A. Feasey, Iruka N. Okeke, Alison H. Holmes, Catrin E. Moore, Christiane Dolecek, H. Rogier van Doorn, Nandini Shetty, Alan D. Lopez, Sharon J. Peacock Improving the estimation of the global burden of antimicrobial resistant infections. The Lancet Infectious Diseases. Vol.19, No.11 (2019), e392-e398. doi:10.1016/S1473-3099(19)30276-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51344
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Improving the estimation of the global burden of antimicrobial resistant infections
Other Contributor(s)
Public Health England
The University of Hong Kong Li Ka Shing Faculty of Medicine
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
University of Cambridge
University of Oxford
University of Melbourne
Imperial College London
Mahidol University
University of Ibadan
Oxford University Clinical Research Unit
The University of Hong Kong Li Ka Shing Faculty of Medicine
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
University of Cambridge
University of Oxford
University of Melbourne
Imperial College London
Mahidol University
University of Ibadan
Oxford University Clinical Research Unit
Abstract
© 2019 Elsevier Ltd Estimating the global burden of disease from infections caused by pathogens that have acquired antimicrobial resistance (AMR) is essential for resource allocation and to inform AMR action plans at national and global levels. However, the scarcity of robust and accepted methods to determine burden is widely acknowledged. In this Personal View, we discuss the underlying assumptions, characteristics, limitations, and comparability of the approaches used to quantify mortality from AMR bacterial infections. We show that the global burdens of AMR estimated in previous studies are not comparable because of their different methodological approaches, assumptions, and data used to generate the estimates. The analytical frameworks from previous studies are inadequate, and we conclude that a new approach to the estimation of deaths caused by AMR infection is needed. The innovation of a new approach will require the development of mechanisms to systematically collect a clinical dataset of substantial breadth and quality to support the accurate assessment of burden, combined with decision-making and resource allocation for interventions against AMR. We define key actions required and call for innovative thinking and solutions to address these problems.